Switzerland buys Pfizer’s COVID-19 antiviral Paxlovid -Breaking
[ad_1]
© Reuters. FILE PHOTO. Coronavirus disease (COVID-19), treatment pill Paxlovid can be seen in boxes at Misericordia in Grosseto in Italy on February 8, 2022. REUTERS/Jennifer Lorenzini/File PhotoBERLIN, (Reuters) – Switzerland signed a contract in order to purchase BERLIN Pfizer (NYSE:) Friday’s announcement by Paxlovid on Friday indicated that the anti-viral drug Paxlovid will be used to treat Covid-19.
European countries announced that they had agreed to 12,000 treatment packages. The first care for patients at high risk would begin in the month.
[ad_2]